HealthQuill Articles by: HealthQuill
Global corporations worldwide are now adapting to a "new normal," where WFH is becoming standard practice, either fully or partially. While seeking a "new normal," there is growing concern about mental health outcomes associated with WFH.  A study examining WFH experiences during lockdown found that most respondents reported more positive than negative experiences. 
Drugs Health Medical

Opinion: Work from home debate rages on as Mental Health Day nears

By Aparna S As we inch toward October 10, Mental Health Day, the ‘Workplace Mental Health’ theme for 2024 needs to be put

Read More
Johnson & Johnson has discontinued its mid-stage trial, evaluating an antiviral drug, mosnodenvir, for the prevention of dengue.
Drugs Health Pharma

Johnson & Johnson stops mid-stage trial of drug for dengue prevention

Johnson & Johnson has discontinued its mid-stage trial, evaluating an antiviral drug, mosnodenvir, for the prevention of dengue.

Read More
Italy’s Recordati will acquire global rights for Sanofi’s drug Enjaymo, used in the treatment of a rare autoimmune disease that causes the body's immune system to attack red blood cells, for an upfront $825 million.
Drugs Health Pharma

Recordati buys Sanofi’s drug for autoimmune disease for $825 million

Italy’s Recordati will acquire global rights for Sanofi’s drug Enjaymo, used in the treatment of a rare autoimmune disease that causes the body's

Read More
Novo Nordisk will invest 864 million reais ($158 million) to revamp its Brazil unit, which accounts for 25% of the drugmaker’s insulin shipments globally.
Climate Drugs Pharma

Denmark’s Novo Nordisk to invest $158 million in Brazil insulin facility

Novo Nordisk will invest 864 million reais ($158 million) to revamp its Brazil unit, which accounts for 25% of the drugmaker’s insulin shipments

Read More
The European Medicines Agency is reviewing two medicines meant to treat hair loss and prostate enlargement following concerns regarding suicidal ideation and behaviours.
Drugs Health Pharma

EMA starts review of medicines to treat hair loss, prostate enlargement

The European Medicines Agency is reviewing two medicines meant to treat hair loss and prostate enlargement following concerns regarding suicidal ideation and behaviours.

Read More
cancer
Drugs Health Pharma

UK scientists receive funding to develop world’s first ovarian cancer vaccine

HQ Team October 4, 2024: Researchers at the University of Oxford have received £600,000 (€719,960) from Cancer Research UK to fund their project

Read More
According to the United Nations, one in ten people worldwide were aged 65 years and above in 2021. By 2050, this number is estimated to be one in six persons globally.
Drugs Health Medical

Geriatric falls a greater economic burden than firearms injuries

HQ Team October 4, 2024: Falls among the elderly population are a leading cause of injury and can lead to immense physical, emotional

Read More
The US state of California has confirmed two human cases of bird flu, bringing the total number of cases in the current year to 16, government data showed.
Drugs Health Medical

California state confirms two cases of bird flu, US total stands at 16 now

The US state of California has confirmed two human cases of bird flu, bringing the total number of cases in the current year

Read More
Climate Health Medical

‘Communities take primacy in any conversation around health’: Interview

In our search for websites and organizations engaged in community health, public policy and similar endeavors, we came across “The Third Eye’.  Named

Read More
Harvard University researchers have developed a drug-free nasal spray that blocks, and neutralizes viruses and bacteria.
Drugs Health Medical

Harvard develops drug-free nasal spray to block viruses, bacteria

Harvard University researchers have developed a drug-free nasal spray that blocks, and neutralizes viruses and bacteria.

Read More
X